BGI Group and China's National Biotech Strategy

BGI Group has been at the forefront of China's national biotech strategy, playing a key role in the country's efforts to become a global leader in the field.

BGI has been actively involved in the development of China's 13th Five-Year Plan for Biotechnology, which aims to make the country a world leader in biotechnology by 2025.

The plan focuses on areas such as precision medicine, synthetic biology, and biomanufacturing, where BGI has made significant contributions.

By 2020, China had become the world's second-largest biotech market, with BGI Group being a major driving force behind this growth.

For more insights, see: Unity Biotechnology

A bill has been introduced to ban foreign adversary biotech firms, including BGI Group, from accessing US taxpayer dollars. The bill, called the BIOSECURE act, aims to protect US national security.

Chairman Mike Gallagher and Ranking Member Raja Krishnamoorthi led the introduction of the bill in the House, while Senators Bill Hagerty, Gary Peters, Mitt Romney, and Roger Marshall introduced corresponding legislation in the Senate.

The legislation would restrict federally funded medical providers from using foreign adversary biotech companies of concern, including BGI Group and its subsidiaries, MGI and Complete Genomics.

BGI Group collects genetic data of Americans and uses it for research with the Chinese military. This has raised concerns about the potential misuse of this data.

The bill aims to address this problem by establishing a regulatory framework to prevent the flow of taxpayer dollars to biotech entities of concern.

Here are some key points about the bill:

The introduction of this bill is a significant step towards protecting US national security and preventing the misuse of genetic data.

The BGI Group has a complex relationship with patents and policy, which is reflected in its history of patent disputes.

The company has been involved in several high-profile patent disputes, including a 2013 lawsuit against a US-based company that alleged BGI had infringed on its patents related to genetic testing.

BGI has also made efforts to establish partnerships and collaborations with other organizations to advance its research and development goals, such as its 2015 partnership with the University of California, San Diego.

Take a look at this: Yorkshire Patent Steam Wagon Co.

Patents play a crucial role in protecting intellectual property and encouraging innovation. The US Patent and Trademark Office (USPTO) issues patents to inventors and businesses that meet certain requirements.

A patent gives the owner the exclusive right to make, use, and sell their invention for a certain period of time, typically 20 years from the date of filing. This allows them to recoup their investment and profit from their innovation.

The cost of obtaining a patent can be high, with fees ranging from $65 to $280 per application. However, the benefits of patent protection can far outweigh these costs.

Patent applications must be specific and detailed, including a description of the invention, its purpose, and how it works. This helps examiners at the USPTO determine whether the invention is novel and non-obvious.

Patents can be granted for a wide range of inventions, from software and business methods to medical devices and consumer products.

On a similar theme: Patent

Patents and policy have a complex relationship, with policy influencing patent law and vice versa. The patent system is designed to incentivize innovation, but it can also be used to stifle competition and limit access to essential technologies.

The US patent system is based on a "first-to-invent" principle, which can lead to disputes over who invented a particular technology first. This principle was changed to a "first-to-file" system in 2013, but the change was met with resistance from some inventors.

Patent trolls, also known as non-practicing entities, are companies that acquire patents solely to litigate and collect licensing fees. They often target small businesses and individuals, draining their resources and stifling innovation.

The US government has implemented policies to combat patent trolls, such as the America Invents Act of 2011. This act requires patent owners to pay fees for each patent they hold, which can help deter trolls from acquiring and hoarding patents.

Patent law can also impact access to essential technologies, such as medical treatments and software. The patent system can make it difficult for researchers to access and build upon existing knowledge, hindering progress in these areas.

Worth a look: Arm's Length Principle

The BGI Group is not the only Chinese national champion in the genomics field. CRISPR Therapeutics, a biotech company, has also made significant contributions to the field, particularly in the area of gene editing.

CRISPR Therapeutics was founded in 2014 by a team of researchers from the University of Pennsylvania and the Broad Institute of MIT and Harvard.

The company has made significant progress in developing gene therapies for genetic diseases using CRISPR-Cas9 technology.